Prime Therapeutics LLC (Prime) is providing notification of changes to section 3: Claims Processing of the Provider Manual effective March 1, 2018, which is incorporated by reference to the Pharmacy Participation Agreement.

Effective January 1, 2018, the TRUEplus and TechLITE pen needles and syringes listed below are the ONLY preferred Pen Needles and Syringes products (for the sizes listed) on the Medicare Part D formularies for Blue Cross MedicareRx (PDP)SM and Blue Cross Medicare AdvantageSM plans.

Effective 1/1/2018, Regence Health Plans, Asuris Northwest Health, and Bridgespan prescription drug plans implemented a utilization management program which limits the duration of therapy of immediate release (IR) single and combination opioid agents, including tramadol products.

Participating Pharmacies may be experiencing claim rejections when trying to process claims for Covered Persons of Florida Blue.

Effective January 1, 2018, Blue Cross Community Health Plans experienced a large increase in their membership.